Building the Bridge Between Clinical Research and Care

Building the Bridge
Between Clinical
Research and Care

Physician taking notes
Physician taking notes
Woman pushing a man in a wheelchair

ABOUT SITERX

ABOUT SITERX

Our Mission

Our Mission

SiteRx is on a mission to make clinical research accessible to all by improving transparency and diversity in clinical trials.

SiteRx is on a mission to make clinical research accessible to all by improving transparency and diversity in clinical trials.

We value compassion

We value compassion

We value security

We value security

We value reliability

We value reliability

STATS

STATS

About Alzheimer’s Disease

About Alzheimer’s Disease

6.7M

6.7M

Americans age 65 and older are living with Alzheimer’s dementia.

Americans age 65 and older are living with Alzheimer’s dementia.

6th

6th

leading cause of death in the US, and leading cause of disability and poor health in adults.

leading cause of death in the US, and leading cause of disability and poor health in adults.

41%

41%

of patients in the US reported knowing nothing about clinical trials.

of patients in the US reported knowing nothing about clinical trials.

73%

73%

of patients reported that their provider was their most trusted source of information on clinical trials.

of patients reported that their provider was their most trusted source of information on clinical trials.

Four coworkers collaborating at a whiteboard

HOW WE DO IT

HOW WE DO IT

Our Process

Our Process

We work with independent neurologists and providers across the US to facilitate efficient access to local clinical trials without the need of becoming a PI, running a research site, or hiring additional staff.

We work with independent neurologists and providers across the US to facilitate efficient access to local clinical trials without the need of becoming a PI, running a research site, or hiring additional staff.

Four coworkers collaborating at a whiteboard
Pharmacist facing away from the camera and looking at shelves full of medication

GETTING STARTED

GETTING STARTED

Did You Know?

Did You Know?

While approved treatments may be few, 79% of Alzheimer’s disease drugs currently in clinical trials are targeting disease modification. As of January 1, 2023, 156 clinical trials were underway testing additional disease-modifying therapies.

While approved treatments may be few, 79% of Alzheimer’s disease drugs currently in clinical trials are targeting disease modification. As of January 1, 2023, 156 clinical trials were underway testing additional disease-modifying therapies.

ABOUT SITERX

ABOUT SITERX

Who We Are

Who We Are

Check out our patient explainer video to learn more about our process, our values, and our commitment to enhancing access to clinical trials for all patients and providers across the US.

Check out our patient explainer video to learn more about our process, our values, and our commitment to enhancing access to clinical trials for all patients and providers across the US.

Ready to Explore Our Platform?

Ready to Explore Our Platform?

Schedule a demo today with your dedicated SiteRx account representative.

Schedule a demo today with your dedicated SiteRx account representative.